Radioactive drug targets advanced prostate cancer in first human trial
NCT ID NCT04644770
Summary
This early-stage study is testing a new radioactive antibody drug called JNJ-69086420 for men with advanced prostate cancer that has spread and stopped responding to standard hormone treatments. The main goal is to find the safest and most effective dose by monitoring side effects in 144 participants. Researchers will also check if the drug shows early signs of slowing cancer growth by measuring prostate-specific antigen (PSA) levels and tumor changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Case Western Reserve University
Cleveland, Ohio, 44106, United States
-
City of Hope
Duarte, California, 91010, United States
-
East Jefferson General Hospital
Metairie, Louisiana, 70006, United States
-
Mayo Clinic Arizona
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Tulane University Hospital & Clinics
New Orleans, Louisiana, 70112, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Utah Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
XCancer Omaha / Urology Cancer Center
Omaha, Nebraska, 68130, United States
Conditions
Explore the condition pages connected to this study.